Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas

Trial Profile

Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Perifosine (Primary) ; Temsirolimus (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 14 Jul 2015 According to the ClinicalTrials.gov record, planned number of patients changed from 17 to 22.
    • 14 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top